Comments on: Use of Epidermal Growth Factor Receptor Mutation Analysis in Patients with Advanced Non-Small-Cell Lung Cancer to Determine Erlotinib Use as First-Line Therapy

Comments on: Use of Epidermal Growth Factor Receptor Mutation Analysis in Patients with Advanced Non-Small-Cell Lung Cancer to Determine Erlotinib Use as First-Line Therapy https://currents.plos.org/genomictests/article/use-of-epidermal-growth-factor-receptor-mutation-analysis-in-patients-with-advanced-non-small-cell-lung-cancer-to-determine-erlotinib-use-as-first-line-therapy/ Fri, 11 Aug 2017 16:36:40 +0000 hourly 1 https://wordpress.org/?v=4.5.3